FDA Adverse Event Injury Summary report: N

POLISHED FINNED TIB TRAY 67MM

MDR report key: 12007238 · Received June 16, 2021

Report

Report Number
0009610576-2021-00004
Event Type
Injury
Date Received
June 16, 2021
Date of Event
June 2, 2021
Report Date
September 9, 2021
Manufacturer
BIOMET SPAIN, S.L.
Product Code
KRO
PMA / PMN Number
SEE H10
Removal / Correction Number
N/A
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
BE
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 0

(B)(4). G5: THIS PRODUCT IS MANUFACTURED BY BIOMET SPAIN ORTHOPAEDICS, S.L. AND IS NOT CLEARED OR DISTRIBUTED IN THE U.S. HOWEVER, THIS REPORT IS BEING SUBMITTED AS ZIMMER BIOMET WARSAW MANUFACTURES A SIMILAR DEVICE THAT IS CLEARED OR DISTRIBUTED IN THE UNITED STATES UNDER 510(K) NUMBER K945028.

Description of Event or Problem · 0

ON (B)(6) 2021, THE PATIENT HAD A REVISION OF A VANGUARD TIBIAL KNEE IMPLANT. THERE WAS NO CEMENT BONDING ON THE TIBIAL PLATEAU OF THE PRIMARY VANGUARD. A REVISION OF A VANGUARD TIBIAL KNEE IMPLANT. THERE WAS NO CEMENT BONDING ON THE TIBIAL PLATEAU OF THE PRIMARY VANGUARD. NO ADDITIONAL INFORMATION.

Additional Manufacturer Narrative · 1

(B)(4). THIS PRODUCT IS MANUFACTURED BY BIOMET (B)(4) ORTHOPAEDICS, S.L. AND IS NOT CLEARED OR DISTRIBUTED IN THE U.S. HOWEVER, THIS REPORT IS BEING SUBMITTED AS ZIMMER BIOMET WARSAW MANUFACTURES A SIMILAR DEVICE THAT IS CLEARED OR DISTRIBUTED IN THE UNITED STATES UNDER 510(K) NUMBER K945028. PRODUCT LOCATION UNKNOWNS.

Description of Event or Problem · 1

ON (B)(6) 2021, THE PATIENT HAD A REVISION OF A VANGUARD TIBIAL KNEE IMPLANT. THERE WAS NO CEMENT BONDING ON THE TIBIAL PLATEAU OF THE PRIMARY VANGUARD. A REVISION OF A VANGUARD TIBIAL KNEE IMPLANT. THERE WAS NO CEMENT BONDING ON THE TIBIAL PLATEAU OF THE PRIMARY VANGUARD. NO ADDITIONAL INFORMATION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
909318 POLISHED FINNED TIB TRAY 67MM PROSTHESIS, KNEE KRO BIOMET SPAIN, S.L. N/A 2012070081

Patients

Seq Age Sex Outcome Treatment
1 Hospitalization| R